// App-Quantinova.ai

: ADRB2 haplotypes and risk of exacerbations in asthmatic children and young adults treated with long-acting ß2-agonists: A meta-analysis in the PiCA consortium

Researchers

Presenter

  • Leila Karimi

Principal Investigators

  • Susanne J. Vijverberg

  • Marjolein Engelkes

  • Natalia Hernandez-Pacheco

  • Niloufar Farzan

  • Patricia Soares

  • Ben R. Francis

  • Maria Pino-Yanes

  • Celeste Eng

  • Somnath Mukhopadhyay

  • Maximilian Schieck

  • Michael Kabesch

  • Esteban G Burchard

  • Colin N.A Palmer

  • Steve Turner

  • Hettie M Janssens

  • Anke-Hilse Maitland-Van Der Zee

  • Katia M Verhamme

Medical Centers

  • Department of Biostatistics, Erasmus University Medical Center, Rotterdam, Netherlands

  • Department of Respiratory Medicine, Amsterdam University Medical Centers (Amsterdam UMC), University of Amsterdam, Amsterdam, Netherlands

  • Research Unit, Hospital Universitario N.S. de Candelaria, Universidad de La Laguna, Santa Cruz de Tenerife, Spain,

  • Academic Department of Paediatrics, Brighton & Sussex Medical School, Brighton, United Kingdom

  • Department of Women's and Children's Health, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom

  • Genomics and Health Group, Department of Biochemistry, Microbiology, Cell Biology and Genetics, Universidad de La Laguna, Santa Cruz de Tenerife, Spain,

  • Department of Academic Paediatrics, Brighton & Sussex Medical School, Brighton, East Sussex, United Kingdom

  • Department of Pediatric Pneumology and Allergy, University Children’s Hospital Regensburg, Regensburg, Germany.

  • Division of Cardiovascular and Diabetes Medicine, University of Dundee, Ninewells Hospital and Medical School,, Dundee, United Kingdom

  • Department of Pediatrics, div. of Respiratory medicine and Allergology, ErasmusMC Sophia Children's Hospital, University Hospital Rotterdam, Rotterdam, Netherlands

Locations

  • Netherlands

  • Spain

  • United Kingdom

  • United States

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved